Dreavia was pleased to take part as an exhibitor at CPHI Frankfurt 2025, one of the most influential global gatherings for the pharmaceutical industry. Hosted at Messe Frankfurt, in Frankfurt, from 28 to 30 October 2025, the event welcomed more than 62,000 professionals and over 2,400 exhibitors representing the full spectrum of the pharma value chain.
Across the three-day exhibition, the Dreavia team engaged in meaningful discussions with existing partners and new contacts, exchanging insights and exploring opportunities to collaborate on forward-thinking pharmaceutical solutions aligned with our mission to Empower Human Potential.
Our presence in Hall 9.1 (Integrated Pharma Section), Booth 9.1D94, generated strong interest among visitors and received excellent feedback for both concept and visual identity. Dreavia was also honored to serve as sponsor of the official event bags, reinforcing brand visibility throughout the venue.
CPHI Frankfurt 2025 offered an energizing platform for dialogue, innovation, and strategic networking. During the event, Dreavia showcased its expanding portfolio of Nutrition and Derma & OTC products, highlighting its continued investment in science-driven healthcare solutions.
Attendees were introduced to Dreavia’s flagship brands—Rontamil, MeandMil, Rontameal, Novalou, Novatopia, and Nasalou—each developed to empower human potential through quality, care, and innovation.
We look forward to continuing these conversations and meeting the global pharma community again at CPHI Milan 2026.
